AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Fangdd Network Group Ltd.

$0.5 -$1.07 (-68.21%)
NASDAQ · 14 Sep 2026 15:18 UTC
Previous Close
$0.51
Day Range
$0.49$0.51
Year Range
$0.49$4.33
Market Cap
3.98M
AVG Volume
929.49K
Trailing/Forward PE
-0.6/-
PEG ratio
0
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
NASDAQUS
Revenue (CNY)
01B2B3B4B20182019202020212022202320242025
DUO Revenue (CNY) by year
PeriodRevenue (CNY)
2025354.82M
2024339.1M
2023284.96M
2022255.29M
2021942.38M
20202.45B
20193.6B
20182.28B
Net Income (CNY)
-1.5B-1B-500M0500M20182019202020212022202320242025
DUO Net Income (CNY) by year
PeriodNet Income (CNY)
2025-84.71M
202430.83M
2023-91.75M
2022-253.01M
2021-1.17B
2020-220.29M
2019-510.39M
2018-12.21M
Operating Income (CNY)
-1B-500M0500M20182019202020212022202320242025
DUO Operating Income (CNY) by year
PeriodOperating Income (CNY)
2025-133.3M
2024-125.66M
2023-265.17M
2022-270.47M
2021-957.29M
2020-226.02M
2019-536.76M
201869.38M
EBITDA (CNY)
-1B-500M0500M20182019202020212022202320242025
DUO EBITDA (CNY) by year
PeriodEBITDA (CNY)
2025-115.38M
2024-125.2M
2023-264.47M
2022-257.89M
2021-951.39M
2020-189.14M
2019-495.27M
201879.92M
Cash Flows (CNY)
-600M-400M-200M0200M20182019202020212022202320242025
DUO Cash Flows (CNY) by year
PeriodCash Flows (CNY)
2025-147.94M
2024-91.61M
2023-13.11M
2022-40.18M
2021-503.65M
2020-51.59M
2019197.61M
2018120.9M
EPS (CNY)
-6000-4000-20000200020182019202020212022202320242025
DUO EPS (CNY) by year
PeriodEPS (CNY)
2025-17.3
20245.66
2023-14.28
2022-666.82
2021-3295.36
2020-674.76
2019-4810.55
2018-858.69
Expenses (CNY)
0500M1B1.5BR&DSG&ACapex20182019202020212022202320242025
DUO Expenses (CNY) by year
PeriodExpenses (CNY)
2025243.92M
2024218.65M
2023306.48M
2022242.2M
20211.07B
2020640.52M
20191.25B
2018415.69M
Cash & Debt (CNY)
0500M1B1.5BCashLong Term DebtShort Term Debt20182019202020212022202320242025
DUO Cash & Debt (CNY) by year
PeriodCash & Debt (CNY)
2025144.2M
2024188.98M
2023137.04M
2022145.93M
2021498.26M
2020852.45M
20191.12B
2018515.07M
Debt ratios
00.10.20.320212022202320242025
DUO Debt ratios by year
PeriodDebt ratios
20250.19
20240.12
20230.08
20220.04
20210.23
Margins
0%10%20%30%20182019202020212022202320242025
DUO Margins by year
PeriodMargins
202517.92%
202418.21%
202314.46%
20229.69%
202111.3%
202016.91%
201921.03%
201820.88%
Return on Capital
-400%-300%-200%-100%0%100%20182019202020212022202320242025
DUO Return on Capital by year
PeriodReturn on Capital
2025-14.63%
20248.04%
2023-47.91%
2022-265.23%
2021-385.66%
2020-15.03%
2019-32.12%
20180.65%
Shares Outstanding
05M10M15M20182019202020212022202320242025
DUO Shares Outstanding by year
PeriodShares Outstanding
202510.06M
202414.15M
20235.59M
2022375.27K
2021357.86K
2020326.54K
2019116.13K
2018166.85K
Book Value Per Share (CNY)
-20000-100000100002000020182019202020212022202320242025
DUO Book Value Per Share (CNY) by year
PeriodBook Value Per Share (CNY)
202557.54
202427.09
202334.25
2022254.2
2021848.59
20204489.48
201913683.18
2018-11191.3
Total Assets (CNY)
02B4B6B20182019202020212022202320242025
DUO Total Assets (CNY) by year
PeriodTotal Assets (CNY)
2025788.26M
2024731.19M
2023769.9M
20221.08B
20211.91B
20204.05B
20194.37B
20182.88B
Employee Count
05001K1.5K2K2019202020212022202320242025
DUO Employee Count by year
PeriodEmployee Count
2025144
2024134
2023130
2022212
2021604
20201.73K
20191.68K
PE Ratio
0200400600800med 17.55Jan 20Feb 20May 25Jun 25Jul 25Aug 25Sep 25
DUO PE Ratio by year
PeriodPE Ratio
Sep 2523
Sep 2525.72
Sep 2523.52
Sep 2523.97
Aug 2516.65
Aug 2510.15
Aug 2510.59
Aug 2511.79
Aug 2512.47
Jul 2515.2
Jul 2515.08
Jul 2515.62
Jul 2516.25
Jun 2515.27
Jun 2518.11
Jun 2516.98
Jun 2522.47
May 2522.79
May 2512.09
May 2512.7
May 2512.29
May 2512.21
Apr 2513.38
Feb 20466.88
Feb 20528.92
Feb 20525.94
Feb 20497.48
Jan 20521.42
Jan 20577.88
Jan 20582.88
Jan 20592.56
Jan 20618.03
Free Cash Flow Yield
-400%-300%-200%-100%0%med -95.83%Jan 25May 25Aug 25Nov 25Feb 26Jun 26Sep 26
DUO Free Cash Flow Yield by year
PeriodFree Cash Flow Yield
Sep 26-77.86%
Sep 26-69.04%
Aug 26-41.32%
Aug 26-70.21%
Aug 26-75.88%
Aug 26-76.53%
Jul 26-84.13%
Jul 26-84.58%
Jul 26-87.12%
Jul 26-76.06%
Jul 26-64.77%
Jun 26-71.83%
Jun 26-55.89%
Jun 26-54.51%
Jun 26-48.09%
May 26-195.8%
May 26-200.4%
May 26-162.37%
May 26-148.11%
May 26-100.19%
Apr 26-109.23%
Apr 26-110.31%
Apr 26-129.4%
Apr 26-141.27%
Mar 26-140.74%
Mar 26-148.06%
Mar 26-136.06%
Mar 26-141.04%
Feb 26-132.14%
Feb 26-137.04%
Feb 26-128.98%
Feb 26-127.32%
Jan 26-108.18%
Jan 26-103.58%
Jan 26-95.1%
Jan 26-94.97%
Jan 26-96.57%
Dec 25-91.71%
Dec 25-89.63%
Dec 25-77.07%
Dec 25-72.1%
Nov 25-336.55%
Nov 25-360.98%
Nov 25-335.41%
Nov 25-308.75%
Oct 25-307.4%
Oct 25-270.19%
Oct 25-229.95%
Oct 25-179.8%
Oct 25-192.8%
Sep 25-156.2%
Sep 25-139.66%
Sep 25-152.69%
Sep 25-149.85%
Aug 25-215.75%
Aug 25-353.89%
Aug 25-339.04%
Aug 25-304.64%
Aug 25-288.04%
Jul 25-236.38%
Jul 25-238.25%
Jul 25-230.01%
Jul 25-221.08%
Jun 25-235.16%
Jun 25-198.29%
Jun 25-211.57%
Jun 25-159.83%
May 25-157.63%
May 25-24.57%
May 25-23.39%
May 25-24.18%
May 25-24.33%
Apr 25-22.21%
Apr 25-16.2%
Apr 25-16.8%
Apr 25-14.02%
Mar 25-12.49%
Mar 25-11.65%
Mar 25-9.08%
Mar 25-7.81%
Feb 25-7.51%
Feb 25-6.53%
Feb 25-5.71%
Feb 25-6.22%
Jan 25-6.43%
Jan 25-6.5%
Jan 25-6.17%
Jan 25-6.99%
Jan 25-5.68%
Dec 24-5.79%
Dec 24-5.8%
Dec 24-5.21%
Dec 24-6.56%
Nov 24-6.57%
Price to Sales
01234med 0.31Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
DUO Price to Sales by year
PeriodPrice to Sales
Sep 260.49
Sep 260.56
Aug 260.93
Aug 260.57
Aug 260.53
Aug 260.53
Jul 260.48
Jul 260.48
Jul 260.46
Jul 260.53
Jul 260.62
Jun 260.56
Jun 260.72
Jun 260.74
Jun 260.84
May 260.21
May 260.21
May 260.26
May 260.28
May 260.28
Apr 260.26
Apr 260.26
Apr 260.22
Apr 260.2
Mar 260.2
Mar 260.19
Mar 260.21
Mar 260.2
Feb 260.21
Feb 260.21
Feb 260.22
Feb 260.22
Jan 260.26
Jan 260.27
Jan 260.3
Jan 260.3
Jan 260.29
Dec 250.31
Dec 250.31
Dec 250.37
Dec 250.39
Nov 250.1
Nov 250.09
Nov 250.1
Nov 250.1
Oct 250.1
Oct 250.12
Oct 250.14
Oct 250.18
Oct 250.17
Sep 250.19
Sep 250.21
Sep 250.2
Sep 250.2
Aug 250.14
Aug 250.08
Aug 250.09
Aug 250.1
Aug 250.1
Jul 250.13
Jul 250.13
Jul 250.13
Jul 250.13
Jun 250.13
Jun 250.15
Jun 250.14
Jun 250.19
May 250.19
May 251.1
May 251.16
May 251.12
May 251.11
Apr 251.22
Apr 251.26
Apr 251.22
Apr 251.46
Mar 251.64
Mar 251.75
Mar 252.25
Mar 252.62
Feb 252.72
Feb 253.13
Feb 253.58
Feb 253.29
Jan 253.18
Jan 253.14
Jan 253.31
Jan 252.92
Jan 253.6
Dec 243.53
Dec 243.52
Dec 243.92
Dec 243.12
Nov 243.11
Nov 240.83
Nov 241.03
Nov 241.69
Nov 241.71
Oct 241.68
Oct 241.8
EV/EBITDA
550600650700750med 640.29Jan 20Jan 20Jan 20Feb 20Feb 20
DUO EV/EBITDA by year
PeriodEV/EBITDA
Feb 20565.1
Feb 20640.29
Feb 20636.67
Feb 20602.18
Jan 20631.2
Jan 20699.64
Jan 20705.69
Jan 20717.42
Jan 20748.3
Price to Book
01234med 0.21Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
DUO Price to Book by year
PeriodPrice to Book
Sep 260.25
Sep 260.28
Aug 260.48
Aug 260.34
Aug 260.32
Aug 260.31
Jul 260.28
Jul 260.28
Jul 260.27
Jul 260.31
Jul 260.37
Jun 260.33
Jun 260.43
Jun 260.44
Jun 260.5
May 260.13
May 260.13
May 260.16
May 260.17
May 260.18
Apr 260.17
Apr 260.17
Apr 260.14
Apr 260.13
Mar 260.13
Mar 260.12
Mar 260.14
Mar 260.13
Feb 260.14
Feb 260.13
Feb 260.14
Feb 260.14
Jan 260.17
Jan 260.18
Jan 260.19
Jan 260.19
Jan 260.19
Dec 250.2
Dec 250.21
Dec 250.24
Dec 250.26
Nov 250.1
Nov 250.09
Nov 250.1
Nov 250.11
Oct 250.11
Oct 250.13
Oct 250.15
Oct 250.19
Oct 250.18
Sep 250.19
Sep 250.21
Sep 250.19
Sep 250.19
Aug 250.13
Aug 250.08
Aug 250.09
Aug 250.1
Aug 250.1
Jul 250.12
Jul 250.12
Jul 250.13
Jul 250.13
Jun 250.12
Jun 250.15
Jun 250.14
Jun 250.18
May 250.18
May 250.97
May 251.02
May 250.99
May 250.98
Apr 251.08
Apr 251.01
Apr 250.97
Apr 251.16
Mar 251.3
Mar 251.4
Mar 251.79
Mar 252.08
Feb 252.17
Feb 252.49
Feb 252.85
Feb 252.62
Jan 252.53
Jan 252.5
Jan 252.64
Jan 252.33
Jan 252.86
Dec 242.81
Dec 242.81
Dec 243.12
Dec 242.48
Nov 242.48
Nov 241.06
Nov 241.32
Nov 242.17
Nov 242.2
Oct 242.15
Oct 242.31
Fangdd Network Group Ltd.
DUO
Stockpicker

Video analysis: DUO

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: DUO

FangDD Reports First Half 2026 Unaudited Financial Results

globenewswire.com · 28 Aug 2026

FangDD Reports First Half 2026 Unaudited Financial Results

SHENZHEN, China, Aug. 28, 2026 (GLOBE NEWSWIRE) -- Fangdd Network Group Ltd. (NASDAQ: DUO) (“FangDD” or “the Company”), a customer-oriented property technology company in China, today announced its unaudited financial results for the six months ended June 30, 2026.

FangDD Received Nasdaq Notification Regarding Minimum Bid Price Requirement

globenewswire.com · 24 Jul 2026

FangDD Received Nasdaq Notification Regarding Minimum Bid Price Requirement

SHENZHEN, China, July 24, 2026 (GLOBE NEWSWIRE) -- Fangdd Network Group Ltd. (Nasdaq: DUO) (“FangDD” or the “Company”) today announced that it has received a written notification from The Nasdaq Stock Market LLC (“Nasdaq”) dated July 22, 2026, indicating that the Company is currently not in compliance with the minimum bid price requirement set forth under Nasdaq Listing Rule 5550(a)(2) (the “Rule”) as the bid price of the Company's Class A ordinary shares had closed below US$1 per share for the last 30 consecutive business days from June 8 through July 21, 2026.

CroíValve Announces Expansion of Series B Financing with $27 Million Additional Capital to Fund DUO Adapt in an Enlarged TANDEM II Study

businesswire.com · 23 Jun 2026

CroíValve Announces Expansion of Series B Financing with $27 Million Additional Capital to Fund DUO Adapt in an Enlarged TANDEM II Study

DUBLIN--(BUSINESS WIRE)--CroíValve, a pioneering medical device company focused on the development of a novel transcatheter device for the treatment of tricuspid regurgitation, announced today the closing of $20 million Series B expansion financing, along with $7 million European Innovation Council (EIC) and DTIF grant financing. Bringing the total for Series B to $36 million, and $43M including grant financing. The financing includes new investors BGF and EIC, along with participation from cur.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.